Is antitumour necrosis factor therapy combined with ultraviolet B phototherapy safe?
Di Lernia
V
V
Albertini
G
G
D003131:Combined Modality Therapy; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D011565:Psoriasis / Q000628:therapy*; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D014467:Ultraviolet Therapy / Q000009:adverse effects*
D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept